(MRTN) Marten Transport - Overview
Stock: Temperature-Controlled Freight, Dry Van, Intermodal, Brokerage, Dedicated
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.93% |
| Yield on Cost 5y | 1.56% |
| Yield CAGR 5y | -22.35% |
| Payout Consistency | 83.7% |
| Payout Ratio | 82.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.7% |
| Relative Tail Risk | -9.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -21.44 |
| Character TTM | |
|---|---|
| Beta | 0.665 |
| Beta Downside | 0.298 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.89% |
| CAGR/Max DD | -0.24 |
Description: MRTN Marten Transport January 19, 2026
Marten Transport Ltd. (NASDAQ:MRTN) is a temperature-sensitive truckload carrier serving shippers across the United States, Mexico and Canada. Founded in 1946 and based in Mondovi, Wisconsin, the firm focuses on refrigerated and insulated freight as well as dry cargo.
The company operates four segments: Truckload (full-load food, consumer packaged goods and dry freight), Dedicated (customized solutions for individual customers), Intermodal (refrigerated containers on rail-flatcars combined with trucking), and Brokerage (arranging third-party carriers for temperature-controlled and dry shipments).
As of 31 December 2024, Marten’s fleet comprised 3,006 tractors, of which 2,918 were owned and 88 were supplied by independent contractors, supported by a mix of refrigerated trailers, dry vans and specialized equipment.
Key recent metrics: 2023 revenue was approximately $1.1 billion with an adjusted EBITDA margin near 7%; capacity utilization averaged 95% in the Truckload segment, reflecting strong demand for cold-chain logistics; and freight rates for temperature-controlled loads rose roughly 5% year-over-year, driven by sustained growth in e-commerce grocery and pharmaceutical shipments.
For a deeper, data-driven view of MRTN’s valuation and risk profile, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 17.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -11.22 > 1.0 |
| NWC/Revenue: 8.99% < 20% (prev 4.67%; Δ 4.32% < -1%) |
| CFO/TA 0.10 > 3% & CFO 93.5m > Net Income 17.4m |
| Net Debt (-43.1m) to EBITDA (120.0m): -0.36 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.5m) vs 12m ago 0.01% < -2% |
| Gross Margin: 5.71% > 18% (prev 0.14%; Δ 557.8% > 0.5%) |
| Asset Turnover: 92.12% > 50% (prev 99.48%; Δ -7.36% > 0%) |
| Interest Coverage Ratio: -1.50 > 6 (EBITDA TTM 120.0m / Interest Expense TTM -9.75m) |
Altman Z'' 7.20
| A: 0.08 (Total Current Assets 171.7m - Total Current Liabilities 92.2m) / Total Assets 949.8m |
| B: 0.75 (Retained Earnings 712.0m / Total Assets 949.8m) |
| C: 0.02 (EBIT TTM 14.6m / Avg Total Assets 959.3m) |
| D: 3.91 (Book Value of Equity 712.9m / Total Liabilities 182.1m) |
| Altman-Z'' Score: 7.20 = AAA |
Beneish M -1.85
| DSRI: 1.11 (Receivables 98.9m/96.9m, Revenue 883.7m/963.7m) |
| GMI: 2.37 (GM 5.71% / 13.56%) |
| AQI: 0.97 (AQ_t 0.00 / AQ_t-1 0.00) |
| SGI: 0.92 (Revenue 883.7m / 963.7m) |
| TATA: -0.08 (NI 17.4m - CFO 93.5m) / TA 949.8m) |
| Beneish M-Score: -1.85 (Cap -4..+1) = B |
What is the price of MRTN shares?
Over the past week, the price has changed by +10.24%, over one month by +7.62%, over three months by +39.07% and over the past year by -9.71%.
Is MRTN a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MRTN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14 | 3.2% |
| Analysts Target Price | 14 | 3.2% |
| ValueRay Target Price | 14.6 | 7.4% |
MRTN Fundamental Data Overview February 01, 2026
P/S = 1.135
P/B = 1.3501
P/EG = 3.2
Revenue TTM = 883.7m USD
EBIT TTM = 14.6m USD
EBITDA TTM = 120.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 388.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -43.1m USD (from netDebt column, last quarter)
Enterprise Value = 960.1m USD (1.00b + Debt 388.0k - CCE 43.3m)
Interest Coverage Ratio = -1.50 (Ebit TTM 14.6m / Interest Expense TTM -9.75m)
EV/FCF = -30.41x (Enterprise Value 960.1m / FCF TTM -31.6m)
FCF Yield = -3.29% (FCF TTM -31.6m / Enterprise Value 960.1m)
FCF Margin = -3.57% (FCF TTM -31.6m / Revenue TTM 883.7m)
Net Margin = 1.97% (Net Income TTM 17.4m / Revenue TTM 883.7m)
Gross Margin = 5.71% ((Revenue TTM 883.7m - Cost of Revenue TTM 833.2m) / Revenue TTM)
Gross Margin QoQ = -17.84% (prev 11.18%)
Tobins Q-Ratio = 1.01 (Enterprise Value 960.1m / Total Assets 949.8m)
Interest Expense / Debt = 217.5% (Interest Expense 844.0k / Debt 388.0k)
Taxrate = 26.76% (1.35m / 5.05m)
NOPAT = 10.7m (EBIT 14.6m * (1 - 26.76%))
Current Ratio = 1.86 (Total Current Assets 171.7m / Total Current Liabilities 92.2m)
Debt / Equity = 0.00 (Debt 388.0k / totalStockholderEquity, last quarter 767.6m)
Debt / EBITDA = -0.36 (Net Debt -43.1m / EBITDA 120.0m)
Debt / FCF = 1.36 (negative FCF - burning cash) (Net Debt -43.1m / FCF TTM -31.6m)
Total Stockholder Equity = 768.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.82% (Net Income 17.4m / Total Assets 949.8m)
RoE = 2.27% (Net Income TTM 17.4m / Total Stockholder Equity 768.5m)
RoCE = 1.71% (EBIT 14.6m / Capital Employed (Total Assets 949.8m - Current Liab 92.2m))
RoIC = 1.39% (NOPAT 10.7m / Invested Capital 768.8m)
WACC = 8.37% (E(1.00b)/V(1.00b) * Re(8.37%) + (debt cost/tax rate unavailable))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.06%
Fair Price DCF = unknown (Cash Flow -31.6m)
EPS Correlation: -94.43 | EPS CAGR: -39.54% | SUE: 1.44 | # QB: 1
Revenue Correlation: -95.13 | Revenue CAGR: -8.00% | SUE: 0.85 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=-0.014 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.28 | Chg30d=-0.040 | Revisions Net=-3 | Growth EPS=+31.4% | Growth Revenue=-1.1%
EPS next Year (2027-12-31): EPS=0.43 | Chg30d=+0.032 | Revisions Net=+0 | Growth EPS=+56.7% | Growth Revenue=+9.7%